These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25541517)

  • 21. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quality by design approach to understand formulation and process variability in pharmaceutical melt extrusion processes.
    Patwardhan K; Asgarzadeh F; Dassinger T; Albers J; Repka MA
    J Pharm Pharmacol; 2015 May; 67(5):673-84. PubMed ID: 25615235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
    Jójárt-Laczkovich O; Szabó-Révész P
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upscaling of the hot-melt extrusion process: comparison between laboratory scale and pilot scale production of solid dispersions with miconazole and Kollicoat IR.
    Guns S; Mathot V; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):674-82. PubMed ID: 22521332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations.
    Almeida A; Saerens L; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Dec; 439(1-2):223-9. PubMed ID: 23018111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical hot melt extrusion process development using QbD and digital twins.
    Matić J; Stanković-Brandl M; Bauer H; Lovey J; Martel S; Herkenne C; Paudel A; Khinast J
    Int J Pharm; 2023 Jan; 631():122469. PubMed ID: 36509223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders.
    Keen JM; Martin C; Machado A; Sandhu H; McGinity JW; DiNunzio JC
    J Pharm Pharmacol; 2014 Feb; 66(2):204-17. PubMed ID: 24433423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples.
    Ooi SM; Sarkar S; van Varenbergh G; Schoeters K; Heng PW
    Ther Deliv; 2013 Apr; 4(4):463-70. PubMed ID: 23557287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Process monitoring and visualization solutions for hot-melt extrusion: a review.
    Saerens L; Vervaet C; Remon JP; De Beer T
    J Pharm Pharmacol; 2014 Feb; 66(2):180-203. PubMed ID: 24433422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inline monitoring and a PAT strategy for pharmaceutical hot melt extrusion.
    Wahl PR; Treffer D; Mohr S; Roblegg E; Koscher G; Khinast JG
    Int J Pharm; 2013 Oct; 455(1-2):159-68. PubMed ID: 23911343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melt extrusion: process to product.
    Repka MA; Shah S; Lu J; Maddineni S; Morott J; Patwardhan K; Mohammed NN
    Expert Opin Drug Deliv; 2012 Jan; 9(1):105-25. PubMed ID: 22145932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
    Qian F; Huang J; Zhu Q; Haddadin R; Gawel J; Garmise R; Hussain M
    Int J Pharm; 2010 Aug; 395(1-2):232-5. PubMed ID: 20562003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution enhancement of itraconazole by hot-melt extrusion alone and the combination of hot-melt extrusion and rapid freezing--effect of formulation and processing variables.
    Lang B; McGinity JW; Williams RO
    Mol Pharm; 2014 Jan; 11(1):186-96. PubMed ID: 24283890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
    Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
    Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid crystal suspensions containing griseofulvin--preparation and bioavailability testing.
    Reitz E; Vervaet C; Neubert RH; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):193-202. PubMed ID: 23108185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drop-on-Demand System for Manufacturing of Melt-based Solid Oral Dosage: Effect of Critical Process Parameters on Product Quality.
    Içten E; Giridhar A; Nagy ZK; Reklaitis GV
    AAPS PharmSciTech; 2016 Apr; 17(2):284-93. PubMed ID: 26082005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between drugs and polymers influencing hot melt extrusion.
    Li Y; Pang H; Guo Z; Lin L; Dong Y; Li G; Lu M; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):148-66. PubMed ID: 24325738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.